(Q87397473)

English

A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema

scientific article published on 28 February 2014

In more languages
default values for all languages
No label defined

No description defined

Statements

A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit